JESSICA PAYNE: Open Payments
NPI 1366177958 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,126 in 47 payments from 11 companies in 2025. Trend: 2023 $657 · 2024 $776 · 2025 $1,126
Food & beverage: $1,016Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $240 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $185 |
| E.R. Squibb & Sons, L.L.C. | 5 | $182 |
| Otsuka America Pharmaceutical, Inc. | 13 | $141 |
| Vanda Pharmaceuticals Inc. | 3 | $138 |
| Neurocrine BioSciences, Inc. | 4 | $95 |
| Alkermes, Inc. | 4 | $81 |
| Corium, LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
Products named: CAPLYTA, COBENFY, INGREZZA, REXULTI, FANAPT, HETLIOZ, UZEDY, AUSTEDO XR.
Industry payments across TN — which companies pay providers there.
